Rapid HIV test for newborns could save lives by getting treatment started faster

NCT ID NCT03133728

Completed Diagnosis Sponsor: University of Alabama at Birmingham Source: ClinicalTrials.gov ↗

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tested a new rapid HIV test for infants in Zambia that gives results in under an hour, compared to standard lab tests that take weeks. Researchers wanted to see if faster diagnosis would lead to more babies starting treatment sooner. Over 1,600 HIV-exposed infants were enrolled, and the test was done at community clinics or homes. The goal was to improve survival and health outcomes for HIV-infected infants.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Alere Q HIV-1/2 Detect Test (diagnostic test)
What this could lead to: If successful, this rapid test could help HIV-infected infants start treatment much sooner, reducing illness and death.
What could go wrong: The test may not be as accurate as standard lab tests, and results may vary in real-world settings. This study was completed, but broader use depends on further validation.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HIV are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

AIDS HIV infectious disease

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

HIV HIV INFECTIONS

Contacts and locations

Locations

George Primary Health Clinic

Lusaka, Zambia
Kalingalinga Primary Health Clinic

Lusaka, Zambia
Kamwala Primary Health Clinic

Lusaka, Zambia
Makeni Primary Health Clinic

Lusaka, Zambia
Matero Ref Primary Health Clinic

Lusaka, Zambia
N'gombe Primary Health Clinic

Lusaka, Zambia

More trials for these conditions

Other studies related to the condition(s) this trial covers.